StockData
Johnson & Johnson logo

Johnson & Johnson

JNJNYSEPharmaceutical PreparationsFiscal year ends January 3
Financials through Q2 FY2026, quarter ended Jun 28, 2026Last filing: 10-Q on Oct 21, 2026Score 12/3042% above fair value
$270.56−2.64 (-0.97%)

Close on Nov 2, 2026Market cap $652.02BP/E 31.4Yield 1.90%

Johnson & Johnson Specialty Surgery [reported separately through FY2019Q4] by Year

Specialty Surgery [reported separately through FY2019Q4] — International operational growth YoY (%) (%)

Johnson & Johnson Specialty Surgery [reported separately through FY2019Q4]: -16.4% in FY2019, down 20.6 pts from a year earlier. No newer figure appears in the documents we track.

Latest, FY2019
-16.4%
Period ended Dec 29, 2019
Change on a year earlier
-20.6 pts
4.2% in FY2018
History
3 years
Since FY2017
Sources
3
Documents cited below

Where the FY2019 figure comes from

“|| Intl | 497 | 625 | (20.5 | ) | (16.4 | ) | (4.1 | )”

Source: Form 8-K (a2019q4exhibit991.htm, filed 2020-01-22) ↗

Reported in Form 8-K EX-99.2 Segment Sales Schedule.

Annual history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedSpecialty Surgery [reported separately through FY2019Q4] — International operational growth YoY (%) (%)Year on yearSource
FY2019Dec 29, 2019-16.4%-20.6 ptsForm 8-K (a2019q4exhibit991.htm, filed 2020-01-22) ↗
FY2018Dec 30, 20184.2%+1.8 ptsForm 8-K (a2018q4exhibit9915.htm, filed 2019-01-22) ↗
FY2017Dec 31, 20172.4%–Form 8-K (a8k2017q4exhibit9915.htm, filed 2018-01-23) ↗

Cite this data

StockData. (2026). Johnson & Johnson Specialty Surgery [reported separately through FY2019Q4] (%), annual FY2017–FY2019 [Data set]. Compiled from Johnson & Johnson SEC filings and investor materials. https://stockdatahq.com/stocks/jnj/kpis/mt-surg-specialty-intl-ops-yoy

See every metric in the Johnson & Johnson KPI table. Data updated Oct 25, 2026.